A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.4 EUR -2.44% Market Closed
Market Cap: 6.3m EUR
Have any thoughts about
Acticor Biotech SA?
Write Note

Acticor Biotech SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Acticor Biotech SA
Revenue Peer Comparison

Comparables:
VLA
NANO
G
GNFT
ALERS
OSE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Acticor Biotech SA
PAR:ALACT
Revenue
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Revenue
€221.6m
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
20%
Nanobiotix SA
PAR:NANO
Revenue
€36.2m
CAGR 3-Years
1 063%
CAGR 5-Years
242%
CAGR 10-Years
70%
G
Genfit SA
PAR:GNFT
Revenue
€84m
CAGR 3-Years
151%
CAGR 5-Years
61%
CAGR 10-Years
29%
Eurobio Scientific SA
PAR:ALERS
Revenue
€144.2m
CAGR 3-Years
-13%
CAGR 5-Years
21%
CAGR 10-Years
17%
OSE Immunotherapeutics SA
PAR:OSE
Revenue
€83.4m
CAGR 3-Years
83%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is Acticor Biotech SA's Revenue?
Revenue
0 EUR

Based on the financial report for Dec 31, 2023, Acticor Biotech SA's Revenue amounts to 0 EUR.

Back to Top